Pfizer Inc. (BVMF:PFIZ34)

Market Cap	784.23B
Revenue (ttm)	335.41B
Net Income (ttm)	52.51B
Shares Out	n/a
EPS (ttm)	9.22
PE Ratio	14.94
Forward PE	8.55
Dividend	1.61 (4.68%)
Ex-Dividend Date	Nov 6, 2025

Volume	11,908
Average Volume	11,689
Open	35.12
Previous Close	35.20
Day's Range	34.37 - 35.39
52-Week Range	30.84 - 41.79
Beta	0.42
RSI	49.13
Earnings Date	Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: PFIZ34

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD